BioHarvest Sciences Inc.
June 22, 2026
Theater 4
Type: Company Presentation
Focus Area:
Platform for Therapeutics
BioHarvest Sciences (NASDAQ: BHST) has spent the past 15 years developing a patented plant cell biomanufacturing platform capable of producing high-value plant-derived bioactives at commercial scale with batch-to-batch consistency, enhanced concentration, and full traceability independent of traditional agriculture.
Company HQ City:
Rehovot
Company HQ State:
Israel
Company HQ Country:
Israel
Year Founded:
2007
Lead Product in Development:
Vinia
CEO
Dr. Zaki Rakib
Development Phase of Lead Product
Multiple Products in Market
Number of Unlicensed Products Looking for Licensing
5
Exchange
NASDAQ
Ticker
BHST
When you expect your next catalyst update?
N/A
What is your next catalyst (value inflection) update?
N/A
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}